Probucol controlled-release tablet for treatment of hypercholesteremia and production method thereof

A technology of hypercholesterolemia and probucol, which is applied in the fields of pharmaceutical formulations, metabolic diseases, active ingredients of sulfur/selenium/tellurium, etc., can solve the problem of low bioavailability of probucol tablets and the absence of probucol preparations Reports on sustained-release tablets and other issues, to achieve drug safety, reduce side effects, and reduce the number of times of taking

Inactive Publication Date: 2013-03-20
广西方略药业集团有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology improves over existing drugs by making them last longer for better treatment or less harmful doses that require multiple pills perday instead of every few hours. It allows users who take medicine on an irregular schedule to have their own way around while keeping up with their prescribed regimen.

Problems solved by technology

This patented technical solution describes how probe molecules called prostaglandins were identified during pregnancy reversible carbodiystrophy syndrome testing procedures conducted over several hours ago. These findings showed potential benefits like reducing inflammation levels associated with plaque buckling metabolism, improves insulitis resistance, treatments target diseases related to platelets activation, and protective agents against apoptosis caused by excess iron deposition.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Probucol controlled-release tablet for treatment of hypercholesteremia and production method thereof
  • Probucol controlled-release tablet for treatment of hypercholesteremia and production method thereof
  • Probucol controlled-release tablet for treatment of hypercholesteremia and production method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1 Probucol Sustained Release Tablets (500mg)

[0038] Prescription composition:

[0039] Element mg / tablet Probuka 500 lactose 80 HPMCK15M 220 PVP-K30 30 5% starch slurry Appropriate amount Magnesium stearate 8 Gastric Opadry 20

[0040] production method:

[0041] Pass the prescribed amount of Probucol through a 100-mesh sieve, and pass the prescribed amount of HPMC-K15M, lactose and PVP-K30 through a 80-mesh sieve. Mix the above raw and auxiliary materials evenly, make soft material with 5% starch slurry, granulate with 18-mesh sieve, dry at 50°C, granulate with 20-mesh sieve, add prescription amount of magnesium stearate, mix evenly, and compress into tablets to obtain Chips, spare;

[0042] Put the above tablet cores into the coating pan, the speed is 30 rpm, the temperature is controlled at 50-60°C, and the prepared gastric-soluble Opadry film coating solution (the prescribed amount of gastric-solub

Embodiment 2

[0043] Example 2 Probucol Sustained Release Tablets (1000mg)

[0044] Prescription composition:

[0045] Element mg / tablet Probuka 1000 microcrystalline cellulose 180 HPMCK100M 350 PVP-K30 50 5% starch slurry Appropriate amount Magnesium stearate 15 Gastric Opadry 35

[0046] production method:

[0047] Pass the prescribed amount of Probucol through a 100-mesh sieve, and pass the prescribed amount of HPMC-K100M, microcrystalline cellulose and PVP-K30 through an 80-mesh sieve respectively. Mix the above raw and auxiliary materials evenly, make soft material with 5% starch slurry, granulate with 18-mesh sieve, dry at 50°C, granulate with 20-mesh sieve, add prescription amount of magnesium stearate, mix evenly, and compress into tablets to obtain Chips, spare;

[0048] Put the above tablet cores into the coating pan, the speed is 30 rpm, the temperature is controlled at 50-60°C, and the prepared gastric-soluble Opadry

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a probucol controlled-release tablet which comprises components in parts by weight: 300-600 of probucol, 40-100 of diluent, 150-300 of controlled-release skeleton substrate, 15-40 of adhesive, 5-12 of lubricant and 12-30 of film coating materials. The probucol spansule is used for the treatment of hypercholesteremia, enables medicaments to release slowly in a body, can keep blood concentration stable and improve the compliance of a patient and lower toxic and side effect, and has curative effect of 24 hours by taking only once each day.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner 广西方略药业集团有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products